Loading clinical trials...
Loading clinical trials...
IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Associazione Italiana per lo Studio del Pancreas
NCT06201234 · Hormone Receptor Positive HER-2 Negative Breast Cancer, Advanced or Metastatic Breast Cancer, and more
NCT04613440 · BRCA1 Mutation, BRCA2 Mutation
NCT04743479 · Pancreatic Cancer, Diabetes, and more
NCT03351803 · BRCA1 Mutation, BRCA2 Mutation
NCT04247503 · Familial Pancreatic Cancer
Istituto Clinico Humanitas
Rozzano, Milan
Ospedale Pederzoli
Peschiera del Garda, Verona
San Raffele Vita Salute University Hospital
Milan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions